Cargando…

Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine

rVSVΔG-ZEBOV-GP vaccine is a live recombinant (r) vesicular stomatitis virus (VSV), where the VSV G protein is replaced with the Zaire Ebola virus (ZEBOV) glycoprotein (GP). For vaccine immunogenicity testing, clinical trial sera collected during an active ZEBOV outbreak underwent gamma irradiation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grant-Klein, Rebecca J., Antonello, Joseph, Nichols, Rick, Dubey, Sheri, Simon, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609194/ https://www.ncbi.nlm.nih.gov/pubmed/31162004 http://dx.doi.org/10.4269/ajtmh.19-0076

Ejemplares similares

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
por: Rupani, Neil, et al.
Publicado: (2022)

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
por: Monath, Thomas P., et al.
Publicado: (2019)

High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
por: Morozov, Igor, et al.
Publicado: (2021)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
por: Wong, Gary, et al.
Publicado: (2014)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018)

A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses
por: Farzani, Touraj Aligholipour, et al.
Publicado: (2020)

Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs
por: Locher, Samira, et al.
Publicado: (2018)

Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein
Publicado: (1979)

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)

Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein
por: Rehman, Sheeba, et al.
Publicado: (2022)

Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses
por: Racine, Trina, et al.
Publicado: (2017)

Incubation Period of Ebola Hemorrhagic Virus Subtype Zaire
por: Eichner, Martin, et al.
Publicado: (2011)

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2012)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate
por: LEE, Hyang-Sim, et al.
Publicado: (2020)

Evaluating Temperature Sensitivity of Vesicular Stomatitis Virus–Based Vaccines
por: Stein, Derek R., et al.
Publicado: (2019)

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
por: Liu, Guodong, et al.
Publicado: (2021)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
por: Saito, Takeshi, et al.
Publicado: (2020)

Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species
por: Bergren, Nicholas A., et al.
Publicado: (2018)

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
por: Matassov, Demetrius, et al.
Publicado: (2015)

Oral Vaccination With Recombinant Vesicular Stomatitis Virus Expressing Sin Nombre Virus Glycoprotein Prevents Sin Nombre Virus Transmission in Deer Mice
por: Warner, Bryce M., et al.
Publicado: (2020)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes
Publicado: (1981)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019)

Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice
por: Park, Jung-Eun, et al.
Publicado: (2021)

Wave-Like Spread of Ebola Zaire
por: Walsh, Peter D, et al.
Publicado: (2005)

The synthetic futures of vesicular stomatitis virus
por: Overend, Christopher, et al.
Publicado: (2012)

Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes
por: Cutts, Todd A., et al.
Publicado: (2020)

Recent Common Ancestry of Ebola Zaire Virus Found in a Bat Reservoir
por: Biek, Roman, et al.
Publicado: (2006)

Impact of spatial dispersion, evolution, and selection on Ebola Zaire Virus epidemic waves
por: Azarian, Taj, et al.
Publicado: (2015)

A sensitive and specific point-of-care detection assay for Zaire Ebola virus
por: Zhang, Xiao-Ai, et al.
Publicado: (2017)

Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing
por: Izumida, Mai, et al.
Publicado: (2020)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
por: Zhu, Wenjun, et al.
Publicado: (2022)

Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo
por: Beier, Kevin T., et al.
Publicado: (2013)

Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice
por: Zhang, Minmin, et al.
Publicado: (2016)

The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells
por: Brinkmann, Constantin, et al.
Publicado: (2017)

Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice
por: Stubbs, Sarah Hulsey, et al.
Publicado: (2021)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u5oiik0k5k5fdlpeede2agqmlr